SCHEMBL517340

SCHEMBL517340

CCN(CC)/[N+]([O-])=N/O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL517339 1.00
SCHEMBL819207 1.00
SCHEMBL517338 1.00
SCHEMBL1525454 0.97 ALOX15 (0.74)
SCHEMBL29394097 0.97 ALOX15 (0.74)
SCHEMBL1374556 0.97 ALOX15 (0.74)
SCHEMBL8089487 0.97 ALOX15 (0.74)
Diethylamine SCHEMBL1524932 0.88 ALOX15 (1.00)
Diethylamine SCHEMBL1524933 0.88 ALOX15 (1.00)
Diethylamine SCHEMBL447262 0.88 ALOX15 (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180036314-A1 METHODS AND COMPOSITIONS FOR TREATING PERIPHERAL VASCULAR DISEASE EXODOS LIFE SCIENCES LP (US) 2018-02-08 US claimed
US-20130053393-A1 METHODS AND COMPOSITIONS FOR TREATING PERIPHERAL VASCULAR DISEASE EXODOS LIFE SCIENCES LIMITED PARTNERSHIP (US) 2013-02-28 US claimed
EP-2512479-A1 METHODS AND COMPOSITIONS FOR TREATING PERIPHERAL VASCULAR DISEASE Exodos Life Sciences Limited Partnership (US) 2012-10-24 EP claimed
WO-2011075655-A1 METHODS AND COMPOSITIONS FOR TREATING PERIPHERAL VASCULAR DISEASE EXODOS LIFE SCIENCES LIMITED PARTNERSHIP (US) 2011-06-23 WO claimed
US-20090326017-A1 PAIN-RELIEVING COMPOSITIONS AND USES THEREFOR THE UNIVERSITY OF QUEENSLAND (AU) 2009-12-31 US claimed
WO-2008098192-A2 COMPOSITIONS AND METHODS FOR TREATING NEUROPATHY MAIBACH TODD (US) 2008-08-14 WO claimed
US-20080193385-A1 COMPOSITIONS AND METHODS FOR TREATING NEUROPATHY MAIBACH TODD 2008-08-14 US claimed
WO-2008080194-A1 PAIN-RELIEVING COMPOSITIONS AND USES THEREFOR THE UNIVERSITY OF QUEENSLAND (AU) 2008-07-10 WO claimed
WO-2007100910-A2 TRANSDERMAL PATCHES CONTAINING A NITRIC OXIDE-DONOR AND A SECOND ACTIVE AGENT AND ASSOCIATED METHODS CURE THERAPEUTICS, INC. (US) 2007-09-07 WO claimed
US-20070202155-A1 Low dose no donor-containing transdermal patch CURE THERAPEUTICS, INC. 2007-08-30 US claimed
WO-2007092284-A2 LOW DOSE NO DONOR-CONTAINING TRANSDERMAL PATCH CURE THERAPEUCTICS, INC. (US) 2007-08-16 WO claimed
US-20070059351-A1 Transdermal patches containing a nitric oxide-donor and a second active agent and associated methods CURE THERAPEUTICS, INC. 2007-03-15 US claimed
US-20030215528-A1 Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype QUEENS UNIVERSITY AT KINGSTON (CA) 2003-11-20 US claimed
US-6586478-B2 Administering nitrogen oxide mimetic CELLEGY CANADA (CA) 2003-07-01 US claimed
WO-2024006841-A2 COMPOSITIONS FOR WEIGHT LOSS AND CANCER TREATMENT KNOWLEDGE PHARMACEUTICALS INC. (US) 2024-01-04 WO disclosed
US-20230346777-A1 USE OF SGC ACTIVATORS FOR THE TREATMENT OF OPHTHALMOLOGIC DISEASES BAYER AG (DE) 2023-11-02 US disclosed
US-20220296584-A1 Membrane Active Molecules KNOWLEDGE PHARMACEUTICALS INC. 2022-09-22 US disclosed
US-20020102744-A1 Monitoring nitrosylation of polypeptide substrates; obtain sample, incubate with alkylthiolating agent, reduce nitrosothiol bonds on subatrate, incubate with tag, detect signal NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2002-08-01 US disclosed
WO-2002039119-A2 METHOD FOR ASSAYING PROTEIN NITROSYLATION THE JOHNS HOPKINS UNIVERSITY (US) 2002-05-16 WO disclosed
US-20020015740-A1 Methods and compositions for improving sleep QUEEN'S UNIVERSITY AT KINGSTON (CA) 2002-02-07 US disclosed